TY - JOUR
T1 - Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
AU - Rahman, Sunniyat
AU - Bloye, Gianna
AU - Farah, Nadine
AU - Demeulemeester, Jonas
AU - Costa, Joana R.
AU - O'Connor, David
AU - Pocock, Rachael
AU - Rapoz-D'Silva, Tanya
AU - Turna, Adam
AU - Wang, Lingyi
AU - Lee, Soo Wah
AU - Fielding, Adele K.
AU - Roels, Juliette
AU - Jaksik, Roman
AU - Dawidowska, Małgorzata
AU - Van Vlierberghe, Pieter
AU - Hadjur, Suzana
AU - Hughes, Jim R.
AU - Davies, James O.J.
AU - Gutierrez, Alejandro
AU - Kelliher, Michelle A.
AU - Van Loo, Peter
AU - Dawson, Mark A.
AU - Mansour, Marc R.
N1 - Publisher Copyright:
© 2024 American Society of Hematology
PY - 2024/11/28
Y1 - 2024/11/28
N2 - Oncogenes can be activated in cis through multiple mechanisms including enhancer hijacking events and noncoding mutations that create enhancers or promoters de novo. These paradigms have helped parse somatic variation of noncoding cancer genomes, thereby providing a rationale to identify noncanonical mechanisms of gene activation. Here we describe a novel mechanism of oncogene activation whereby focal copy number loss of an intronic element within the FTO gene leads to aberrant expression of IRX3, an oncogene in T-cell acute lymphoblastic leukemia (T-ALL). Loss of this CTCF-bound element downstream to IRX3 (+224 kb) leads to enhancer hijack of an upstream developmentally active super-enhancer of the CRNDE long noncoding RNA (−644 kb). Unexpectedly, the CRNDE super-enhancer interacts with the IRX3 promoter with no transcriptional output until it is untethered from the FTO intronic site. We propose that “promoter tethering” of oncogenes to inert regions of the genome is a previously unappreciated biological mechanism preventing tumorigenesis.
AB - Oncogenes can be activated in cis through multiple mechanisms including enhancer hijacking events and noncoding mutations that create enhancers or promoters de novo. These paradigms have helped parse somatic variation of noncoding cancer genomes, thereby providing a rationale to identify noncanonical mechanisms of gene activation. Here we describe a novel mechanism of oncogene activation whereby focal copy number loss of an intronic element within the FTO gene leads to aberrant expression of IRX3, an oncogene in T-cell acute lymphoblastic leukemia (T-ALL). Loss of this CTCF-bound element downstream to IRX3 (+224 kb) leads to enhancer hijack of an upstream developmentally active super-enhancer of the CRNDE long noncoding RNA (−644 kb). Unexpectedly, the CRNDE super-enhancer interacts with the IRX3 promoter with no transcriptional output until it is untethered from the FTO intronic site. We propose that “promoter tethering” of oncogenes to inert regions of the genome is a previously unappreciated biological mechanism preventing tumorigenesis.
UR - https://www.scopus.com/pages/publications/85208015949
UR - https://www.scopus.com/pages/publications/85208015949#tab=citedBy
U2 - 10.1182/blood.2024024300
DO - 10.1182/blood.2024024300
M3 - Article
C2 - 39316719
AN - SCOPUS:85208015949
SN - 0006-4971
VL - 144
SP - 2319
EP - 2326
JO - Blood
JF - Blood
IS - 22
ER -